A typology-based decisional framework to support market access and reimbursement decisions for personalised medicines

dc.contributor.author	Govaerts, Laurenz
dc.contributor.author	Geldof, Tine
dc.contributor.author	Simoens, Steven
dc.contributor.author	Huys, Isabelle
dc.date.accessioned	2018-01-23T14:37:23Z
dc.date.available	2018-01-23T14:37:23Z
dc.date.issued	2017
dc.identifier.issn	1098-3015
dc.identifier.doi	10.1016/j.jval.2017.08.1586
dc.identifier.uri	http://hdl.handle.net/20.500.12127/5898
dc.description.abstract	New co-development approaches in personalized medicine challenge current decisional frameworks of health-technology access and reimbursement procedures. We aim to conceptualize an efficient typology-based decisional framework which takes into account the development and market access synchronism between therapeutic (Tx) and diagnostic (Dx) components of personalized medicines.
dc.language.iso	en
dc.publisher	Blackwell Pub.
dc.subject	Healthcare
dc.subject	Clinical Pharmacology
dc.subject	Pharmacotherapy
dc.title	A typology-based decisional framework to support market access and reimbursement decisions for personalised medicines
dc.identifier.journal	Value in Health. The Journal of the International Society for Pharmacoeconomics and Outcomes Research
dc.source.volume	20
dc.source.issue	9
dc.source.beginpage	A661
dc.source.endpage	A661
dc.contributor.department	KU Leuven
dc.identifier.eissn	1524-4733
vlerick.knowledgedomain	Special Industries : Healthcare Management
vlerick.typearticle	Journal article
vlerick.vlerickdepartment	TOM
dc.identifier.vperid	176581
dc.identifier.vperid	31183

Name:

Publisher version